allergone 8 mg kapsler, hårde
orifarm generics a/s - acrivastin - kapsler, hårde - 8 mg
benadryl 8 mg kapsler, hårde
mcneil denmark aps - acrivastin - kapsler, hårde - 8 mg
robinul-neostigmin 0,5 + 2,5 mg/ml injektionsvæske, opløsning
viatris aps - glycopyrroniumbromid, neostigminmethylsulfat - injektionsvæske, opløsning - 0,5 + 2,5 mg/ml
isoptin retard 120 mg depottabletter
paranova danmark a/s - verapamilhydrochlorid - depottabletter - 120 mg
isoptin sr 120 mg depottabletter
orifarm a/s - verapamilhydrochlorid - depottabletter - 120 mg
tagrisso
astrazeneca ab - osimertinib mesilate - carcinom, ikke-småcellet lunge - andre antineoplastiske midler, protein kinase hæmmere - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
hexasoptin retard 120 mg depotkapsler, hårde
sandoz a/s - verapamilhydrochlorid - depotkapsler, hårde - 120 mg
isoptin retard 120 mg depottabletter
viatris aps - verapamilhydrochlorid - depottabletter - 120 mg
isoptin retard 120 mg depottabletter
europharma.dk aps - verapamilhydrochlorid - depottabletter - 120 mg